AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

CCRIS 7067

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

77 API Suppliers, 27 USDMF, 9 CEP/COS, 6 JDMF, 3 EU WC, 7 KDMF, 26 NDC API, 2 VMF, 51 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

232 Drugs in Development

232 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 130 FDA Orange Book, 113 Europe, 26 Canada, 10 Australia, 14 South Africa, 68 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 1.5MG, TABLET;ORAL - 0.5MG, TABLET;ORAL - 4MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 2MG, SOLUTION;ORAL - 0.5MG/5ML, ELIXIR;ORAL - 0.5MG/5ML, TABLET;ORAL - 1MG, TABLET;ORAL - 6MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 7 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 29 Thickeners and Stabilizers, 25 Solubilizers, 23 Direct Compression, 21 Controlled & Modified Release, 21 Parenteral, 21 Topical, 19 Film Formers & Plasticizers, 17 Disintegrants & Superdisintegrants, 17 Taste Masking, 16 Granulation, 13 Co-Processed Excipients, 12 Lubricants & Glidants, 11 Rheology Modifiers, 9 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 267 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 110 Regulatory FDF Prices, 6 Annual Reports

MARKET PLACE

62 APIs, 59 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 2 USP, 2 JP, 8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
24/02/2025	Pfizer CentreOne	U.S.A	PHARMACIA AND UPJOHN CO LLC WHOLLY OWNED SUB OF PFIZER INC	4524	DEXAMETHASONE USP MICRONIZED	1982-05-10	Active	II	Complete	2013-03-06	2013-02-14
24/02/2025	Symbiotec Pharmalab	India	SYMBIOTEC PHARMALAB PRIVATE LTD	38162	DEXAMETHASONE USP	2023-03-29	Active	II	Complete	2023-10-26	2023-10-03

CCRIS 7067

CCRIS 7067

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

77 API Suppliers

27 USDMF

9 CEP/COS

6 JDMF

3 EU WC

7 KDMF

26 NDC API

2 VMF

51 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

232 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers

130 FDA Orange Book

113 Europe

26 Canada

10 Australia

14 South Africa

68 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%

OINTMENT;OPHTHALMIC - 0.1%;0.3%

SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

TABLET;ORAL - 1.5MG

TABLET;ORAL - 0.5MG

TABLET;ORAL - 4MG

TABLET;ORAL - 0.75MG

TABLET;ORAL - 2MG

SOLUTION;ORAL - 0.5MG/5ML

ELIXIR;ORAL - 0.5MG/5ML

TABLET;ORAL - 1MG

TABLET;ORAL - 6MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

7 SPI Pharma

10 DKSH

1 Pharm-RX Chemical

5 Faran Shimi Pharmaceutical

6 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

15 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 BASF

10 Corel Pharma Chem

1 Curia

6 DFE Pharma

3 Finar

8 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

1 Novo Excipients

1 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

30 Roquette

15 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd